Boston Scientific Liberty Stent Groomed To Face Next-Gen Cobalt Competitors
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will enroll approximately 400 patients in an ongoing clinical trial to support a PMA supplement for the firm's Taxus Liberty stent platform